Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$4.99M Buy
74,620
+534
+0.7% +$36.1K 0.08% 156
2014
Q1
$4.95M Sell
74,086
-1,262
-2% -$85.3K 0.09% 151
2013
Q4
$5.03M Sell
75,348
-169
-0.2% -$11K 0.09% 150
2013
Q3
$4.74M Sell
75,517
-267
-0.4% -$17.2K 0.08% 149
2013
Q2
$4.73M Buy
+75,784
New +$4.81M 0.1% 145

Other funds holding GSK

Wilmington Trust's GSK Position: Q2 2014 in Review

Wilmington Trust increased its GSK (GSK) stake by 0.72% in Q2 2014, buying an estimated $36.1K and bringing the position to 74,620 shares worth $4.99M. The position accounts for 0.08% of the portfolio, ranked #156.

Wilmington Trust first reported a position in GSK in Q2 2013 and has held it in 5 quarters since. The position peaked at $5.03M in Q4 2013. 723 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

  • Wilmington Trust held 74,620 shares of GSK worth $4.99M as of Q2 2014.
  • Wilmington Trust bought 534 GSK shares in Q2 2014, an estimated $36.1K.
  • GSK made up 0.08% of Wilmington Trust's portfolio in Q2 2014, its #156 holding.
  • Wilmington Trust first reported a position in GSK in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust's GSK position peaked at $5.03M in Q4 2013.
  • 723 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.